086890 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The main products consist of Abcertin, Fabagal, clotinap, etc. The company was founded on March 28, 2001 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
086890 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company